The University of Warwick Library - WebBridge

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis) : an open-label, randomised, phase 3 trial
Earl, Helena M..  The Lancet Oncology.  v. 16. no. 6.   2015-06. p. 656 - 666... issn: 1470-2045 .   

Online access not found

Sorry - based on the information provided, WebBridge cannot offer appropriate links.